BLT 0.00% 2.6¢ benitec biopharma limited

when back to 20c, page-5

  1. 2,326 Posts.
    lightbulb Created with Sketch. 12
    i reckon next price sensitive ann will be update on the stem cell CoH trials -due anytime, some thought on SScene by end of Jan.

    it's been underway long enough, and hasn't been shut down by FDA, so can't be a dangerous failure. CoH are advertising for more patients to take part. Might have been a couple of dud results.

    also expect an ann on T Cell therapy IND filing and maybe even commencement of T Cell clinical trial (PI) before court & USPTO sorted.

    and the ann that we will never see coming but always lurks is a buyout
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.